The DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.
Role of FGF23 in vitamin D and phosphate metabolism: Implications in chronic kidney disease
Open accessAbstract
FGF23 is a bone-derived hormone that regulates systemic phosphate homeostasis, vitamin D metabolism and α-klotho expression through a novel bone-kidney axis. FGF23 inhibits renal tubular reabsorption of phosphate through mechanisms independent of PTH as well as reduces circulating 1, 25(OH)2D through its dual effects to suppress Cyp27b1 production and to stimulate Cyp24 catabolism of 1,25(OH)2D. 1,25(OH)2D and other factors regulating bone remodeling/mineralization are the major physiological regulators of FGF23 expression. FGF23 also suppresses the gene transcription of α-klotho by the kidney, which exists as a membrane and soluble protein. Membrane Klotho acts as a coreceptor for and dictates organ specificity of FGF23, whereas soluble Klotho act as an endocrine factor that regulates activity of cell surface glycoproteins and receptors in multiple tissues. Elevated FGF23 levels are responsible for several hereditary and acquired hypophosphatemic rickets disorders. FGF23 and Klotho deficiency have similar phenotypes characterized by hyperphosphatemia, elevated 1,25(OH)2D and tumoral calcinosis. FGF23 levels progressively increase during chronic kidney disease (CKD). FGF23 has been proposed to be the initial adaptive response leading to reductions in 1,25(OH)2D and secondary hyperparathyroidism (HPT) in CKD. The overall biological effect of this initial step may be to orchestrate a coordinated adaptation to protect the organism from the adverse effects of excess phosphate retention. The second step involves the effects of PTH on bone remodeling that further stimulates FGF23 production through both direct and indirect mechanisms related to alterations in extracellular matrix factors. PTH further amplifies FGF23 expression in later stages of CKD to compensate for the increased phosphate efflux from bone caused by excessive bone turnover. While many aspects of the regulation and functions of FGF23 remain to be established, the idea that FGF23 hormone is the initial adaptive hormonal response in CKD that suppresses 1,25(OH)2D, reduces gastrointestinal calcium and phosphate absorption and leads to a secondary HPT represents a paradigm shift in the conceptualization of the pathogenesis of secondary hyperparathyroidism. In addition, the prevalent thought that CKD is a functional “vitamin D deficient state” requiring therapy with 1,25(OH)2D analogues is challenged by effects of FGF23 to potentially lower both 25(OH)D and 1,25(OH)D by induction of Cyp24-mediated degradation. Finally, increments in FGF23 are associated with increased cardiovascular mortality in CKD. Whether these effects represent direct effects of FGF23 or represent a marker of other abnormalities in CKD remain to be determined.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
Mineral Metabolism, Mortality, and Morbidity in Maintenance Hemodialysis
Block, G. A., Klassen, P. S., Lazarus, J. M., Ofsthun, N., Lowrie, E. G., & Chertow, G. M. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000133041.27682.a2 · Cited by 2,687
Moe, S., Drüeke, T., Cunningham, J., Goodman, W., Martin, K., Olgaard, K., Ott, S., Sprague, S., Lameire, N., & Eknoyan, G. (2006) · Kidney International · doi:10.1038/sj.ki.5000414 · Cited by 1,993
Klotho converts canonical FGF receptor into a specific receptor for FGF23
Urakawa, I., Yamazaki, Y., Shimada, T., Iijima, K., Hasegawa, H., Okawa, K., Fujita, T., Fukumoto, S., & Yamashita, T. (2006) · Nature · doi:10.1038/nature05315 · Cited by 1,850
Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis
Gutiérrez, O. M., Mannstadt, M., Isakova, T., Rauh-Hain, J. A., Tamez, H., Shah, A., Smith, K., Lee, H., Thadhani, R., Jüppner, H., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706130 · Cited by 1,727
Shimada, T., Kakitani, M., Yamazaki, Y., Hasegawa, H., Takeuchi, Y., Fujita, T., Fukumoto, S., Tomizuka, K., & Yamashita, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19081 · Cited by 1,596
Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia
Shimada, T., Mizutani, S., Muto, T., Yoneya, T., Hino, R., Takeda, S., Takeuchi, Y., Fujita, T., Fukumoto, S., & Yamashita, T. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.101545198 · Cited by 1,457
Regulation of Fibroblast Growth Factor-23 Signaling by Klotho
Kurosu, H., Ogawa, Y., Miyoshi, M., Yamamoto, M., Nandi, A., Rosenblatt, K. P., Baum, M. G., Schiavi, S., Hu, M.-C., Moe, O. W., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.c500457200 · Cited by 1,366
Feng, J. Q., Ward, L. M., Liu, S., Lu, Y., Xie, Y., Yuan, B., Yu, X., Rauch, F., Davis, S. I., Zhang, S., et al. (2006) · Nature Genetics · doi:10.1038/ng1905 · Cited by 1,199 · cited 1×
“FGF23 appears to coordinate renal phosphate handling to match bone mineralization/remodeling (12, 47, 51, 71), which impact upon the influx and efflux of calcium and phosphate from bone (64, 76, 94) (i.”
BackgroundSelf-citationThe parathyroid is a target organ for FGF23 in rats
Ben-Dov, I. Z., Galitzer, H., Lavi-Moshayoff, V., Goetz, R., Kuro-o, M., Mohammadi, M., Sirkis, R., Naveh-Many, T., & Silver, J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32409 · Cited by 951
Gutierrez, O., Isakova, T., Rhee, E., Shah, A., Holmes, J., Collerone, G., Ju[Combining Diaeresis]ppner, H., & Wolf, M. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005010052 · Cited by 921
Rosen, C. J. (2011) · New England Journal of Medicine · doi:10.1056/nejmcp1009570 · Cited by 816
Fliser, D., Kollerits, B., Neyer, U., Ankerst, D. P., Lhotta, K., Lingenhel, A., Ritz, E., & Kronenberg, F. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006080936 · Cited by 699
Larsson, T., Nisbeth, U. L. F., Ljunggren, Ö., Jüppner, H., & Jonsson, K. B. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00328.x · Cited by 689
Georges, G. T., Nájera, O., Sowers, K., & Sowers, J. R. (2017) · Cardiorenal Medicine · doi:10.1159/000449476 · Cited by 680
FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting
Riminucci, M., Collins, M. T., Fedarko, N. S., Cherman, N., Corsi, A., White, K. E., Waguespack, S., Gupta, A., Hannon, T., Econs, M. J., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18399 · Cited by 657
Fibroblast Growth Factor 23 Is a Counter-Regulatory Phosphaturic Hormone for Vitamin D
Liu, S., Tang, W., Zhou, J., Stubbs, J. R., Luo, Q., Pi, M., & Quarles, L. D. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005111185 · Cited by 642
Self-citationKlotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule
Hu, M. C., Shi, M., Zhang, J., Pastor, J., Nakatani, T., Lanske, B., Razzaque, M. S., Rosenblatt, K. P., Baum, M. G., Kuro‐O, M., et al. (2010) · The FASEB Journal · doi:10.1096/fj.10-154765 · Cited by 578
Moe, S. M., Zidehsarai, M. P., Chambers, M. A., Jackman, L. A., Radcliffe, J. S., Trevino, L. L., Donahue, S. E., & Asplin, J. R. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.05040610 · Cited by 564
Yamashita, T., Yoshioka, M., & Itoh, N. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3696 · Cited by 554
Sitara, D., Razzaque, M. S., Hesse, M., Yoganathan, S., Taguchi, T., Erben, R. G., J+APw-ppner, H., & Lanske, B. (2004) · Matrix Biology · doi:10.1016/j.matbio.2004.09.007 · Cited by 542
Ferrari, S. L., Bonjour, J.-P., & Rizzoli, R. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1039 · Cited by 518
Regulation of Fibroblastic Growth Factor 23 Expression but Not Degradation by PHEX
Liu, S., Guo, R., Simpson, L. G., Xiao, Z.-S., Burnham, C. E., & Quarles, L. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304544200 · Cited by 508
Self-citationAn FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia
Benet-Pagès, A., Orlik, P., Strom, T. M., & Lorenz-Depiereux, B. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi034 · Cited by 507
Larsson, T., Marsell, R., Schipani, E., Ohlsson, C., Ljunggren, Ö., Tenenhouse, H. S., Jüppner, H., & Jonsson, K. B. (2004) · Endocrinology · doi:10.1210/en.2003-1768 · Cited by 499
Pathogenic role of Fgf23 in Hyp mice
Liu, S., Zhou, J., Tang, W., Jiang, X., Rowe, D. W., & Quarles, L. D. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00008.2006 · Cited by 495
Self-citationSeverely Reduced Production of Klotho in Human Chronic Renal Failure Kidney
Koh, N., Fujimori, T., Nishiguchi, S., Tamori, A., Shiomi, S., Nakatani, T., Sugimura, K., Kishimoto, T., Kinoshita, S., Kuroki, T., et al. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.4226 · Cited by 494
Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23
White, K. E., Carn, G., Lorenz-Depiereux, B., Benet-Pages, A., Strom, T. M., & Econs, M. J. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00064.x · Cited by 493
Circulating FGF-23 Is Regulated by 1α,25-Dihydroxyvitamin D3 and Phosphorus in Vivo
Saito, H., Maeda, A., Ohtomo, S.-I., Hirata, M., Kusano, K., Kato, S., Ogata, E., Segawa, H., Miyamoto, K.-I., & Fukushima, N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m408903200 · Cited by 471
Endocrine functions of bone in mineral metabolism regulation
Quarles, L. D. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36479 · Cited by 459
Self-citationRegulation of C-Terminal and Intact FGF-23 by Dietary Phosphate in Men and Women
Burnett, S.-A. M., Gunawardene, S. C., Bringhurst, F. R., Jüppner, H., Lee, H., & Finkelstein, J. S. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060507 · Cited by 455
Lavi-Moshayoff, V., Wasserman, G., Meir, T., Silver, J., & Naveh-Many, T. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00360.2010 · Cited by 441
Perwad, F., Azam, N., Zhang, M. Y. H., Yamashita, T., Tenenhouse, H. S., & Portale, A. A. (2005) · Endocrinology · doi:10.1210/en.2005-0777 · Cited by 425
Polypeptide GalNAc-transferase T3 and Familial Tumoral Calcinosis
Kato, K., Jeanneau, C., Tarp, M. A., Benet-Pagès, A., Lorenz-Depiereux, B., Bennett, E. P., Mandel, U., Strom, T. M., & Clausen, H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602469200 · Cited by 423
Dietary Phosphorus Regulates Serum Fibroblast Growth Factor-23 Concentrations in Healthy Men
Antoniucci, D. M., Yamashita, T., & Portale, A. A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0021 · Cited by 421
Kolek, O. I., Hines, E. R., Jones, M. D., LeSueur, L. K., Lipko, M. A., Kiela, P. R., Collins, J. F., Haussler, M. R., & Ghishan, F. K. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00243.2005 · Cited by 409
How Fibroblast Growth Factor 23 Works
Liu, S., & Quarles, L. D. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007010068 · Cited by 408
Self-citationMortality risk among hemodialysis patients receiving different vitamin D analogs
Tentori, F., for the Medical Directors of Dialysis Clinic Inc., Hunt, W. C., Stidley, C. A., Rohrscheib, M. R., Bedrick, E. J., Meyer, K. B., Johnson, H. K., & Zager, P. G. (2006) · Kidney International · doi:10.1038/sj.ki.5001868 · Cited by 391
Vitamin D receptor-independent FGF23 actions in regulating phosphate and vitamin D metabolism
Shimada, T., Yamazaki, Y., Takahashi, M., Hasegawa, H., Urakawa, I., Oshima, T., Ono, K., Kakitani, M., Tomizuka, K., Fujita, T., et al. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00474.2004 · Cited by 360
Early Control of PTH and FGF23 in Normophosphatemic CKD Patients: A New Target in CKD-MBD Therapy?
Oliveira, R. B., Cancela, A. L. E., Graciolli, F. G., Dos Reis, L. M., Draibe, S. A., Cuppari, L., Carvalho, A. B., Jorgetti, V., Canziani, M. E., & Moysés, R. M. A. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.05420709 · Cited by 357
Serum FGF23 Levels in Normal and Disordered Phosphorus Homeostasis
Weber, T. J., Liu, S., Indridason, O. S., & Quarles, L. D. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.7.1227 · Cited by 354
Self-citationImmunohistochemical Localization of Klotho Protein in Brain, Kidney, and Reproductive Organs of Mice
Li, S.-A., Watanabe, M., Yamada, H., Nagai, A., Kinuta, M., & Takei, K. (2004) · Cell Structure and Function · doi:10.1247/csf.29.91 · Cited by 351
Hasegawa, H., Nagano, N., Urakawa, I., Yamazaki, Y., Iijima, K., Fujita, T., Yamashita, T., Fukumoto, S., & Shimada, T. (2010) · Kidney International · doi:10.1038/ki.2010.313 · Cited by 341
Young, E. W., Akiba, T., Albert, J. M., McCarthy, J. T., Kerr, P. G., Mendelssohn, D. C., & Jadoul, M. (2004) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(04)01103-5 · Cited by 333
Bai, X., Miao, D., Li, J., Goltzman, D., & Karaplis, A. C. (2004) · Endocrinology · doi:10.1210/en.2004-0233 · Cited by 329
Forging Forward with 10 Burning Questions on FGF23 in Kidney Disease
Wolf, M. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009121293 · Cited by 308
Paternally Inherited Inactivating Mutations of the GNAS1 Gene in Progressive Osseous Heteroplasia
Shore, E. M., Ahn, J., de Beur, S. J., Li, M., Xu, M., Gardner, R. J. M., Zasloff, M. A., Whyte, M. P., Levine, M. A., & Kaplan, F. S. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011262 · Cited by 294
The osteoblast: An insulin target cell controlling glucose homeostasis
Clemens, T. L., & Karsenty, G. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.321 · Cited by 278
FGF-23 in patients with end-stage renal disease on hemodialysis
Imanishi, Y., Inaba, M., Nakatsuka, K., Nagasue, K., Okuno, S., Yoshihara, A., Miura, M., Miyauchi, A., Kobayashi, K., Miki, T., et al. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00604.x · Cited by 272
MEPE has the properties of an osteoblastic phosphatonin and minhibin
Rowe, P. S. N., Kumagai, Y., Gutierrez, G., Garrett, I. R., Blacher, R., Rosen, D., Cundy, J., Navvab, S., Chen, D., Drezner, M. K., et al. (2004) · Bone · doi:10.1016/j.bone.2003.10.005 · Cited by 268
Self-citationRhee, Y., Bivi, N., Farrow, E., Lezcano, V., Plotkin, L. I., White, K. E., & Bellido, T. (2011) · Bone · doi:10.1016/j.bone.2011.06.025 · Cited by 262
Craver, L., Marco, M. P., Martinez, I., Rue, M., Borras, M., Martin, M. L., Sarro, F., Valdivielso, J. M., & Fernandez, E. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfl718 · Cited by 262
Kuro-o, M. (2010) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-009-0722-7 · Cited by 256
Galitzer, H., Ben-Dov, I. Z., Silver, J., & Naveh-Many, T. (2010) · Kidney International · doi:10.1038/ki.2009.464 · Cited by 246
Acute effect of oral phosphate loading on serum fibroblast growth factor 23 levels in healthy men
Nishida, Y., Taketani, Y., Yamanaka-Okumura, H., Imamura, F., Taniguchi, A., Sato, T., Shuto, E., Nashiki, K., Arai, H., Yamamoto, H., et al. (2006) · Kidney International · doi:10.1038/sj.ki.5002000 · Cited by 243
Effects of Dietary Phosphate and Calcium Intake on Fibroblast Growth Factor-23
Vervloet, M. G., van Ittersum, F. J., Büttler, R. M., Heijboer, A. C., Blankenstein, M. A., & ter Wee, P. M. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04730510 · Cited by 218
Angiogenesis and Vasculogenesis Are Impaired in the Precocious-Aging klotho Mouse
Shimada, T., Takeshita, Y., Murohara, T., Sasaki, K.-I., Egami, K., Shintani, S., Katsuda, Y., Ikeda, H., Nabeshima, Y.-I., & Imaizumi, T. (2004) · Circulation · doi:10.1161/01.cir.0000139854.74847.99 · Cited by 215
Bone as a source of FGF23: regulation by phosphate?
Mirams, M., Robinson, B. G., Mason, R. S., & Nelson, A. E. (2004) · Bone · doi:10.1016/j.bone.2004.06.014 · Cited by 213
Analysis of the Biochemical Mechanisms for the Endocrine Actions of Fibroblast Growth Factor-23
Yu, X., Ibrahimi, O. A., Goetz, R., Zhang, F., Davis, S. I., Garringer, H. J., Linhardt, R. J., Ornitz, D. M., Mohammadi, M., & White, K. E. (2005) · Endocrinology · doi:10.1210/en.2005-0670 · Cited by 213
Takeshita, K., Fujimori, T., Kurotaki, Y., Honjo, H., Tsujikawa, H., Yasui, K., Lee, J.-K., Kamiya, K., Kitaichi, K., Yamamoto, K., et al. (2004) · Circulation · doi:10.1161/01.cir.0000124224.48962.32 · Cited by 210
PTH receptor signaling in osteocytes governs periosteal bone formation and intracortical remodeling
Rhee, Y., Allen, M. R., Condon, K., Lezcano, V., Ronda, A. C., Galli, C., Olivos, N., Passeri, G., O'Brien, C. A., Bivi, N., et al. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.304 · Cited by 208
Kawata, T., Imanishi, Y., Kobayashi, K., Miki, T., Arnold, A., Inaba, M., & Nishizawa, Y. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006070783 · Cited by 208
Tsuji, K., Maeda, T., Kawane, T., Matsunuma, A., & Horiuchi, N. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.65 · Cited by 203
Stubbs, J. R., Idiculla, A., Slusser, J., Menard, R., & Quarles, L. D. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009040451 · Cited by 192
Self-citationHuman 25-Hydroxyvitamin D3-24-Hydroxylase, a Multicatalytic Enzyme
Beckman, M. J., Tadikonda, P., Werner, E., Prahl, J., Yamada, S., & DeLuca, H. F. (1996) · Biochemistry · doi:10.1021/bi960658i · Cited by 189
Mirza, M. A. I., Alsiö, J., Hammarstedt, A., Erben, R. G., Michaëlsson, K., Tivesten, Å., Marsell, R., Orwoll, E., Karlsson, M. K., Ljunggren, Ö., et al. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.214619 · Cited by 181
FGF23–parathyroid interaction: implications in chronic kidney disease
Komaba, H., & Fukagawa, M. (2010) · Kidney International · doi:10.1038/ki.2009.466 · Cited by 165
Isakova, T., Gutierrez, O. M., Smith, K., Epstein, M., Keating, L. K., Juppner, H., & Wolf, M. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq419 · Cited by 165
Sitara, D., Razzaque, M. S., St‐Arnaud, R., Huang, W. Y., Taguchi, T., Erben, R. G., & Lanske, B. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.060329 · Cited by 153
Relevant use of Klotho in FGF19 subfamily signaling system in vivo
Tomiyama, K.-I., Maeda, R., Urakawa, I., Yamazaki, Y., Tanaka, T., Ito, S., Nabeshima, Y., Tomita, T., Odori, S., Hosoda, K., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913986107 · Cited by 152
FGFR3 and FGFR4 Do not Mediate Renal Effects of FGF23
Liu, S., Vierthaler, L., Tang, W., Zhou, J., & Quarles, L. D. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007121301 · Cited by 144
Self-citationNagano, N., Miyata, S., Abe, M., Kobayashi, N., Wakita, S., Yamashita, T., & Wada, M. (2006) · Kidney International · doi:10.1038/sj.ki.5000020 · Cited by 138
Novel Regulators of Fgf23 Expression and Mineralization in Hyp Bone
Liu, S., Tang, W., Fang, J., Ren, J., Li, H., Xiao, Z., & Quarles, L. D. (2009) · Molecular Endocrinology · doi:10.1210/me.2009-0085 · Cited by 134
Self-citationFibroblast Growth Factor-23 Mutants Causing Familial Tumoral Calcinosis Are Differentially Processed
Larsson, T. E., Davis, S. I., Garringer, H. J., Mooney, S. D., Draman, M. S., Cullen, M. J., & White, K. E. (2005) · Endocrinology · doi:10.1210/en.2005-0431 · Cited by 132
Stubbs, J., Liu, S., & Quarles, L. D. (2007) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2007.00308.x · Cited by 123
Self-citationEvidence for a bone-kidney axis regulating phosphate homeostasis
Quarles, L. D. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319687 · Cited by 122
Self-citationSato, T., Tominaga, Y., Ueki, T., Goto, N., Matsuoka, S., Katayama, A., Haba, T., Uchida, K., Nakanishi, S., Kazama, J. J., et al. (2004) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2004.05.026 · Cited by 118
Bone Formation Regulates Circulating Concentrations of Fibroblast Growth Factor 23
Samadfam, R., Richard, C., Nguyen‐Yamamoto, L., Bolivar, I., & Goltzman, D. (2009) · Endocrinology · doi:10.1210/en.2009-0472 · Cited by 106
Regulation of plasma fibroblast growth factor 23 by calcium in primary hyperparathyroidism
Kobayashi, K., Imanishi, Y., Miyauchi, A., Onoda, N., Kawata, T., Tahara, H., Goto, H., Miki, T., Ishimura, E., Sugimoto, T., et al. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.02053 · Cited by 103
Brown, W. W., Jüppner, H., Langman, C. B., Price, H. E., Farrow, E., White, K. E., & McCormick, K. L. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0220 · Cited by 99
Compound deletion of Fgfr3 and Fgfr4 partially rescues the Hyp mouse phenotype
Li, H., Martin, A., David, V., & Quarles, L. D. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00499.2010 · Cited by 98
Self-citationLiu, S., Rowe, P. S., Vierthaler, L., Zhou, J., & Quarles, L. D. (2007) · Journal of Endocrinology · doi:10.1677/joe.1.07059 · Cited by 92
Self-citationExpression of FGF23 is correlated with serum phosphate level in isolated fibrous dysplasia
Kobayashi, K., Imanishi, Y., Koshiyama, H., Miyauchi, A., Wakasa, K., Kawata, T., Goto, H., Ohashi, H., Koyano, H. M., Mochizuki, R., et al. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.09.052 · Cited by 85
Saji, F., Shigematsu, T., Sakaguchi, T., Ohya, M., Orita, H., Maeda, Y., Ooura, M., Mima, T., & Negi, S. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00169.2010 · Cited by 85
Recent progress in the treatment of vascular calcification
O'Neill, W. C., & Lomashvili, K. A. (2010) · Kidney International · doi:10.1038/ki.2010.334 · Cited by 80
Fibroblast growth factor 23 and bone metabolism in children with chronic kidney disease
van Husen, M., Fischer, A., Lehnhardt, A., Klaassen, I., Möller, K., Müller-Wiefel, D. E., & Kemper, M. J. (2010) · Kidney International · doi:10.1038/ki.2010.107 · Cited by 76
Fukumoto, S., & Yamashita, T. (2002) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200207000-00003 · Cited by 74
FGF-23, vitamin D and calcification: the unholy triad
Razzaque, M. S., St‐Arnaud, R., Taguchi, T., & Lanske, B. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh991 · Cited by 71
van de Graaf, S. F. J., Boullart, I., Hoenderop, J. G. J., et al. (2004) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2004.03.029 · Cited by 70
The Antisenescence Protein Klotho Is Necessary for FGF23-Induced Phosphaturia
Urakawa, I., Yamazaki, Y., Shimada, T., Iijima, K., Hasegawa, H., Okawa, K., Fujita, T., Fukumoto, S., & Yamashita, T. (2007) · Journal of the American Society of Nephrology · doi:10.1681/01.asn.0000926868.48235.3d · Cited by 63
Regulation of Fibroblast Growth Factor 23 Production in Bone in Uremic Rats
Saji, F., Shiizaki, K., Shimada, S., Okada, T., Kunimoto, K., Sakaguchi, T., Hatamura, I., & Shigematsu, T. (2009) · Nephron Physiology · doi:10.1159/000210389 · Cited by 56
Tebben, P. J., Singh, R. J., Clarke, B. L., & Kumar, R. (2004) · Mayo Clinic Proceedings · doi:10.4065/79.12.1508 · Cited by 53
Wetmore, J. B., & Quarles, L. D. (2008) · Nature Reviews Nephrology · doi:10.1038/ncpneph0977 · Cited by 53
Self-citationFGF23 is a putative marker for bone healing and regeneration
Goebel, S., Lienau, J., Rammoser, U., Seefried, L., Wintgens, K. F., Seufert, J., Duda, G. N., Jakob, F. J., & Ebert, R. (2009) · Journal of Orthopaedic Research® · doi:10.1002/jor.20857 · Cited by 46
'Dem bones' are made for more than walking
Quarles, L. D. (2011) · Nature Medicine · doi:10.1038/nm0411-428 · Cited by 42
Self-citation
Cited by
Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects
Christakos, S., Dhawan, P., Verstuyf, A., Verlinden, L., & Carmeliet, G. (2016) · Physiological Reviews · doi:10.1152/physrev.00014.2015 · Cited by 1,957
Kenkre, J., & Bassett, J. (2018) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1177/0004563218759371 · Cited by 693
Vascular Calcification—New Insights into Its Mechanism
Lee, S. J., Lee, I.-K., & Jeon, J.-H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082685 · Cited by 438
Muscle and bone, two interconnected tissues
Tagliaferri, C., Wittrant, Y., Davicco, M.-J., Walrand, S., & Coxam, V. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.03.002 · Cited by 390
Vitamin D, calcium homeostasis and aging
Veldurthy, V., Wei, R., Oz, L., Dhawan, P., Jeon, Y. H., & Christakos, S. (2016) · Bone Research · doi:10.1038/boneres.2016.41 · Cited by 356
Metadata
- Authors
- Quarles, L. D.
- Venue
- Experimental Cell Research
- Publisher
- Elsevier BV
- Published
- 2012-05
- Volume
- 318
- Issue
- 9
- Pages
- 1040-1048
- ISSN
- 0014-4827 (ISSN-L)
- OpenAlex
- W2168322307
- Cited by
- 298
- References
- 95
- FWCI
- 18.06
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.